PharmaJet’s Needle-free intradermal (ID) injection device (“Tropis® ID”) will be evaluated as delivery system for the tuberculin skin test (TST) in a clinical study conducted by REDE-TB. The study ...
We’ve explored how prompt injections exploit the fundamental architecture of LLMs. So, how do we defend against threats that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results